ARRAY BIOPHARMA INC's ticker is ARRY and the CUSIP is 04269X105. A total of 171 filers reported holding ARRAY BIOPHARMA INC in Q4 2016. The put-call ratio across all filers is 0.59 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $39,273,000 | +56.0% | 4,467,957 | +19.8% | 0.01% | +50.0% |
| Q3 2016 | $25,181,000 | +103.7% | 3,730,517 | +7.4% | 0.00% | +100.0% |
| Q2 2016 | $12,363,000 | +21.8% | 3,472,853 | +0.9% | 0.00% | 0.0% |
| Q1 2016 | $10,152,000 | -29.8% | 3,441,224 | +0.5% | 0.00% | 0.0% |
| Q4 2015 | $14,453,000 | -6.1% | 3,424,911 | +1.5% | 0.00% | -33.3% |
| Q3 2015 | $15,393,000 | -44.7% | 3,375,599 | -12.5% | 0.00% | -25.0% |
| Q2 2015 | $27,819,000 | -6.8% | 3,858,334 | -4.8% | 0.00% | -20.0% |
| Q1 2015 | $29,858,000 | +58.9% | 4,051,292 | +2.0% | 0.01% | +66.7% |
| Q4 2014 | $18,787,000 | +33.3% | 3,971,863 | +0.6% | 0.00% | +50.0% |
| Q3 2014 | $14,094,000 | -17.3% | 3,947,943 | +5.6% | 0.00% | -33.3% |
| Q2 2014 | $17,048,000 | -3.4% | 3,738,695 | -0.4% | 0.00% | 0.0% |
| Q1 2014 | $17,640,000 | +2.2% | 3,753,233 | +8.9% | 0.00% | 0.0% |
| Q4 2013 | $17,261,000 | -12.6% | 3,445,237 | +8.5% | 0.00% | -25.0% |
| Q3 2013 | $19,744,000 | -3.8% | 3,174,320 | -29.8% | 0.00% | 0.0% |
| Q2 2013 | $20,527,000 | – | 4,521,442 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Redmile Group, LLC | 15,978,580 | $268,121,000 | 9.11% |
| BVF INC/IL | 4,672,195 | $78,399,000 | 7.65% |
| First Light Asset Management, LLC | 2,391,575 | $40,131,000 | 6.25% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 694,500 | $11,647,000 | 4.47% |
| Copernicus Capital Management, LLC | 286,797 | $4,812,000 | 3.49% |
| PACIFIC VIEW ASSET MANAGEMENT, LLC | 225,511 | $3,784,000 | 3.00% |
| SECTORAL ASSET MANAGEMENT INC | 1,566,477 | $26,285,000 | 2.94% |
| X-Square Capital, LLC | 173,802 | $2,917,000 | 2.18% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 2,618,654 | $43,941,000 | 1.48% |
| Birchview Capital, LP | 128,000 | $2,148,000 | 1.46% |